Logo

American Heart Association

  48
  0


Final ID:

Discussant: MAPLE-HCM Responder Analysis

  • Hegde, Sheila  ( University of Texas Southwestern Medical Center , Dallas , Texas , United States )
  • Saberi, Sara  ( University of Michigan , Ann Arbor , Michigan , United States )
  • Author Disclosures:
    Sheila Hegde: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Cytokinetics:Active (exists now) ; Advisor:Cytokinetics:Past (completed) ; Other (please indicate in the box next to the company name):Bristol Myers Squibb:Active (exists now) | Sara Saberi: DO have relevant financial relationships ; Consultant:Cytokinetics, Inc:Active (exists now) ; Research Funding (PI or named investigator):Edgewise:Expected (by end of conference) ; Research Funding (PI or named investigator):Novartis:Past (completed) ; Research Funding (PI or named investigator):Lexicon:Active (exists now) ; Research Funding (PI or named investigator):Bristol Myers Squibb:Active (exists now) ; Research Funding (PI or named investigator):Cytokinetics, Inc:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

From Madrid to Mardi Gras: Heart Failure Trials on Parade

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
How will RCTs change guidelines and clinical practice

Heidenreich Paul

Blood Pressure and Symptomatic Hypotension with Dapagliflozin vs. Placebo in Patients Hospitalized with Heart Failure

Patel Siddharth, Verma Subodh, Wiviott Stephen, Sabatine Marc, Berg David, Palazzolo Michael, Belohavek Jan, Desai Akshay, Drozdz Jaroslaw, Inzucchi Silvio, Mcmurray John, Merkely Bela, Omeara Eileen

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available